dc.creatorDi Ianni, Mauricio Emiliano
dc.creatorTalevi, Alan
dc.date.accessioned2017-12-20T21:18:26Z
dc.date.accessioned2018-11-06T11:08:57Z
dc.date.available2017-12-20T21:18:26Z
dc.date.available2018-11-06T11:08:57Z
dc.date.created2017-12-20T21:18:26Z
dc.date.issued2014-02
dc.identifierDi Ianni, Mauricio Emiliano; Talevi, Alan; How Can Network-Pharmacology Contribute to Antiepileptic Drug Development?; Smart Science & Technology; Molecular and Cellular Epilepsy; 1; 2-2014; 21-28
dc.identifier2330-3883
dc.identifierhttp://hdl.handle.net/11336/31186
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1846414
dc.description.abstractNetwork-pharmacology is a field of pharmacology emerging from the observation that most clinical drugs have multiple targets, contrasting with the previously dominant magic bullet paradigm which proposed the search of exquisitely selective drugs. What is more, drug targets are often involved in multiple diseases and frequently present co-expression patterns. Therefore, useful therapeutic information can be drawn from network representations of drug targets. Here, we discuss potential applications of drug-target networks in the field of antiepileptic drug development.
dc.languagespa
dc.publisherSmart Science & Technology
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.smartscitech.com/index.php/MCE/article/view/30
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDRUG-PROTEIN NETWORKS
dc.subjectNETWORK ANALYSIS
dc.subjectEPILEPSY
dc.subjectDRUG REPOSITIONING
dc.titleHow Can Network-Pharmacology Contribute to Antiepileptic Drug Development?
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución